Risk of relapse in new cases of ulcerative colitis and indeterminate colitis

Diseases of the Colon and Rectum

Volumn 39, Issue 9, 1996, Pages 1019-1025

  Stewénius, Jan ^a,b   Adnerhill, Ingvar ^a   Ekelund, Göran R ^a   Florén, Claes Henrik ^a   Fork, Frans Thomas ^a   Janzon, Lars ^a   Lindström, Clas ^a   Ögren, Mats ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b HELSINGBORG HOSPITAL   (Sweden)

Author keywords

Extent; Indeterminate colitis; Inflammation; Relapse; Ulcerative colitis

Indexed keywords

CORTICOSTEROID; ENEMA; SALAZOSULFAPYRIDINE;

ADULT; AGED; ARTICLE; BARIUM ENEMA; CHILD; CLINICAL FEATURE; COHORT ANALYSIS; COLITIS; COLONOSCOPY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORBIDITY; RELAPSE; REMISSION; RISK FACTOR; SURVIVAL; ULCERATIVE COLITIS;

EID: 0029810081     PISSN: 00123706     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02054693     Document Type: Article

References (17)

1. Broström O. Prognosis in ulcerative colitis. Med Clin North Am 1990;74:201-18.
2. Stewénius J, Adnerhill I, Ekelund G, et al. Ulcerative colitis and indeterminate colitis in the city of Malmö, Sweden, 1958 to 1982: a 25-year incidence study. Scand J Gastroenterol 1995;30:38-43.
3. Stewénius J, Adnerhill I, Andersson H, et al. Incidence of colorectal cancer and all cause mortality in non-selected patients with ulcerative colitis and indeterminate colitis. Int J Colorectal Dis 1995;10:117-22.
4. Stewénius J, Adnerhill I, Ekelund GR, et al. Surgical interventions in non-selected patients with ulcerative colitis and indeterminate colitis: a long term follow-up study (in press).
5. Evans JG, Acheson ED. An epidemiological study of ulcerative colitis and regional enteritis in the Oxford area. Gut 1965;6:311-24.
6. Truelove SC, Wins LJ. Cortisone in ulcerative colitis, final report on a therapeutic trial. BMJ 1955;2:1041-8.
7. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
8. Cox DR. Regression models and life-tables. J R Stat Soc 1972(B);34:187-220.
9. Softley A, Clamp SE, Watkinson G, et al. The natural history of inflammatory bowel disease: has there been a change in the last 20 years. Scand J Gastroenterol 1988; 23(Suppl 144):20-3.
10. Sinclair TS, Brunt PW, Mowat NA. Nonspecific proctocolitis in northeastern Scotland: a community study. Gastroenterology 1983;85:1-11.
11. Henriksen C, Kreiner S, Binder V. Long term prognosis in ulcerative colitis - based on results from a regional patient group from the county of Copenhagen. Gut 1985;26:158-63.
12. Samuelsson S-M. Ulcerative colitis in the county of Uppsala: clinical, epidemiological and sociomedical aspects (thesis). University of Uppsala, Sweden, 1976. ISBN 91-554-0421-9.
13. Tysk C, Järnerot G. Ulcerative proctocolitis in Örebro, Sweden: a retrospective epidemiological study, 1963-1987. Scand J Gastroenterol 1992;27:945-50.
14. Stonnington CM, Phillips SF, Zinsmeister AR, Melton LJ III. Prognosis of chronic ulcerative colitis in a community. Gut 1987;28:1261-6.
15. Powell-Tuck J, Ritchie JK, Lennard-Jones JE. The prognosis of idiopathic proctitis. Scand J Gastroenterol 1977;12:727-32.
16. Misiewicz JJ, Lennard-Jones JE, Connell AM, et al. Controlled trial of sulphasalazine in maintenance therapy for ulcerative colitis. Lancet 1965;1:185-8.
17. Dissanayake AS, Truelove SC. A controlled therapeutic trial of long-term maintenance treatment of ulcerative colitis with sulphasalazine (Salazopyrin). Gut 1973;14:923-6.